Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer

Published:2015-06 Issue:6 Volume:108 Page:djv394
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI.J

Author:

Santoro Valeria,Jia Ruochen,Thompson Hannah,Nijhuis Anke,Jeffery Rosemary,Kiakos Konstantinos,Silver Andrew R.,Hartley John A.,Hochhauser Daniel

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/108/6/djv394/17315141/djv394.pdf

Reference44 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors

2. ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics

3. Understanding resistance to EGFR inhibitors—impact on future treatment strategies

4. EGFR Antagonists in Cancer Treatment

5. K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas;EMBO Molecular Medicine;2024-08-05

2. Reactive oxygen species in colorectal cancer adjuvant therapies;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

3. Chemotherapeutic regulation of the ROS/MondoA-dependent TXNIP/GDF15 axis; and derivation of a new organoid metric as a predictive biomarker;2023-08-14

4. Isolinderalactone Resistance to the Liver Injury Induced by Oxaliplatin in Rats Through Inhibiting IL-6/STAT3 Signal Pathway;Anti-Cancer Agents in Medicinal Chemistry;2023-07-10

5. Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in Colorectal Cancer;Antioxidants & Redox Signaling;2023-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3